BioSpace News Archive

Amendola Communications, a nationally recognized, award-winning healthcare and health IT public relations and marketing firm, announced that TransformativeMed has engaged the agency to provide strategic PR and content marketing services.

Parvizi Surgical Innovation, LLC (PSI) has made a minority investment in a development-stage hip replacement surgery device company, Navbit Holdings Pty Ltd, based in Sydney, Australia.

The U.S. Food and Drug Administration today announced it has authorized the marketing of two new tobacco products manufactured by 22nd Century Group Inc. – Moonlight and Moonlight Menthol, which are combusted, filtered cigarettes that contain a reduced amount of nicotine compared to typical commercial cigarettes.

Shandong Fontacea Pharmaceutical Co. Ltd. (“Fontacea”) announced today that it has entered into an exclusive license, development and commercialization agreement with Janssen Biotech, Inc., to develop and commercialize pharmaceutical products containing a human IgG1λ anti-human IL-17A neutralizing monoclonal antibody in People’s Republic of China

Kelyniam Global (OTC:KLYG), a maker of custom craniomaxilofacial (CMF) implants, announced today that the company has signed a distribution agreement with SurgicalOne, a leading surgical specialty distribution company covering 10 States.

Oncologic Drugs Advisory Committee Voted That LYNPARZA Demonstrated a Favorable Benefit-Risk Profile for Patients Based on Phase 3 POLO Trial Results

Stratify Genomics, a pioneer in genetic cancer risk tests for the general population, announced a commercial partnership with Orig3n, the leader in lifestyle genetic testing.

House overwhelmingly passes year-end spending deal that includes a permanent repeal of the 2.3% medical device tax, Senate likely to approve

Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced that positive results from the ongoing TransCarotid Artery Revascularization (TCAR) Surveillance Project comparing TCAR and transfemoral carotid artery stenting (TF-CAS) have been published in The Journal of the American Medical Association (JAMA)1.

Endo International plc announced that members of management will present at the J.P. Morgan Healthcare Conference in San Francisco, California on Monday, January 13, 2020 at 3:30 p.m. PST.